Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy
Chemoradiotherapy in patients with pancreatic carcinoma: Phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine
N. Oya, K. Shibuya, and T. Sakamoto Chemoradiotherapy in patients with pancreatic carcinoma: Phase-I study with a fixed radiation dose and escalating doses of weekly gemcitabine Pancreatology 6 2006 109 116
Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer
K. Shibuya, N. Oya, and T. Fujii Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer Am J Clin Oncol 34 2011 115 119
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group
C.G. Moertel, S. Frytak, and R.G. Hahn Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group Cancer 48 1981 1705 1710
Eastern Cooperative Oncology Group phase i trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity
M.S. Talamonti, P.J. Catalano, and D.J. Vaughn Eastern Cooperative Oncology Group phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: A regimen with unexpected early toxicity J Clin Oncol 18 2000 3384 3389
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
C.H. Crane, J.L. Abbruzzese, and D.B. Evans Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293 1302
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer
J.D. Murphy, S. Adusumilli, and K.A. Griffith Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 68 2007 801 808
Radiation dose-volume effects in the stomach and small bowel
B.D. Kavanagh, C.C. Pan, and L.A. Dawson Radiation dose-volume effects in the stomach and small bowel Int J Radiat Oncol Biol Phys 76 3 Suppl. 2010 S101 S107
Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma
H.M. Ceha, G. van Tienhoven, and D.J. Gouma Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma Cancer 89 2000 2222 2229
Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
T. Okusaka, Y. Ito, and H. Ueno Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer Br J Cancer 91 2004 673 677
Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer
Y. Ito, T. Okusaka, and Y. Kagami Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer Anticancer Res 26 Suppl. 5B 2006 3755 3759
(2006)Anticancer Res, vol.26, Issue.SUPPL. 5B, pp. 3755-3759
A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer
J.D. Murphy, C. Christman-Skieller, and J. Kim A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer Int J Radiat Oncol Biol Phys 78 2010 1420 1426